About

Providing straightforward information pertaining to drugs, drug use & drug policy. The Grey Pages promotes drug-related literacy and advocates a system of viable and tolerant drug policies. This is my personal collection of commentaries, essays, tid-bits, and other such writings on everything ranging from drug use, drug policy and drug-myths, to drug-science, addiction, human behavior, and the workings of the human brain. I started this blog with a particular focus on opioids, and over the past year have found my interest gravitate toward the intriguing, ever-changing world of designer intoxicants (i.e. "research chemicals" or "designer drugs").

Tuesday, February 28, 2012

Atomoxetine Vault

Atomoxetine 

Trade Names: 

Strattera, Attentin, Tomoxetin

Basic:

Known chemically as (-)-N-methyl-3-phenyl-3-(o-tolyloxy)-propylamine. Atomoxetine is a drug of the NRI (norepinephrine reuptake inhibitor) class. It is not structurally related to the amphetamine family.

Mode of Action:

Atomoxetine is a selective norepinephrine reuptake inhibitor, with negligible effect on dopamine or serotonin transport. It is believed to inhibit the NMDA complex at therapeutic dosages.

Use:

Atomoxetine is used clinically in the treatment of ADHD, and is best known by the brand name Strattera. It has also been used recreationally, and described as a more functional alternative to amphetamines.

In the clinical setting, the drug is taken orally in doses ranging from 10 to 100 milligrams. It may effectively be taken once or twice daily.

Effects:

Atomoxetine differs from other stimulants such as methylphenidate or amphetamine in that its psychostimulant effects are less pronounced than these compounds. It may increase alertness, focus, and energy but produce a lesser degree of euphoria or reward than other popular stimulants. Its effects likely include wakefulness, jitteriness, and increased heart rate. 

Precautions:

Signs of overdose include mydriasis, blurred vision, sweating, confusion, tachycardia, and palpitations. 

Legality:

Atomoxetine is currently not a controlled substance in the US.

1 comment:

  1. http://www.youtube.com/watch?v=Q6dlzb1IHmU&feature=plcp

    an important video on the subject

    ReplyDelete